Abstract
Hypertensive emergencies and hypertensive urgencies (see definitions below) are commonly encountered by a wide variety of clinicians. It is estimated that 1–2 % of patients with hypertension will develop a hypertensive crises at some point in their lifespan. The epidemiology of hypertensive emergencies parallels the distribution of essential hypertension with a higher incidence among the elderly and African-Americans [1, 2]. Prompt recognition, evaluation and appropriate treatment of these conditions are crucial to prevent permanent end organ damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaplan NM. Treatment of hypertensive emergencies and urgencies. Heart Dis Stroke. 1992;1:373–8.
Potter JF. Malignant hypertension in the elderly. Q J Med. 1995;88:641–7.
James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guidelines for the management of high blood pressure in adults. Report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 Report. JAMA. 2003;289:2560–72.
The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1993;153:154–83.
Tumlin JA, Dunbar LM, Oparil S, et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group. Acad Emerg Med. 2000;7:653–62.
Tisdale JE, Huang MB, Borzak S. Risk factors for hypertensive crisis: importance of out-patient blood pressure control. Fam Pract. 2004;21:420–4.
Shea S, Misra D, Ehrlich MH, et al. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776–81.
Saguner AM, Dur S, Perrig M, et al. Risk factors promoting hypertensive crises: evidence from a longitudinal study. Am J Hypertens. 2010;23:775–80.
Katz JN, Gore JM, Amin A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J. 2009;158:599–606.
Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949–62.
van den Born BJ, Honnebier UP, Koopmans RP, et al. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension. 2005;45:246–51.
Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118:214–27.
Garcia JYJ, Vidt DG. Current management of hypertensive emergencies. Drugs. 1987;34:263–78.
Prisant LM, Carr AA, Hawkins DW. Treating hypertensive emergencies. Controlled reduction of blood pressure and protection of target organs. Postgrad Med. 1990;93:92–6.
Ziegler MG. Advances in the acute therapy of hypertension. Crit Care Med. 1992;20:1630–1.
Rey E, LeLorier J, Burgess E, et al. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ. 1997;157:1245–54.
Pasch T, Schulz V, Hoppenshauser G. Nitroprusside-induced formation of cyanide and its detoxication with thiosulfate during deliberate hypotension. J Cardiovasc Pharmacol. 1983;5:77–85.
Marik PE, Varon J. Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth. 2009;21:220–9.
Singla N, Warltier DC, Gandhi SD, et al. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg. 2008;107:59–67.
Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110–21.
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.
Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med. 2007;33:230–6.
Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29:1036–42.
Gocmen R, Ozgen B, Oguz KK. Widening the spectrum of PRES: series from a tertiary care center. Eur J Radiol. 2007;62:454–9.
Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006;27:2179–90.
Servillo G, Striano P, Striano S, et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med. 2003;29:2323–6.
Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol. 2002;23:1038–48.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Marik, P.E. (2015). Hypertensive Crises. In: Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-11020-2_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-11020-2_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11019-6
Online ISBN: 978-3-319-11020-2
eBook Packages: MedicineMedicine (R0)